Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Abcellera Biologics Inc (ABCL)

8.37   -0.2 (-2.33%) 01-25 23:29
Open: 8.4 Pre. Close: 8.57
High: 8.74 Low: 8.1
Volume: 1,566,803 Market Cap: 2,357M
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, AI-powered drug discovery platform searches and analyzes the database of natural immune systems to find antibodies that can be developed as drugs. As of December 31, 2020, the company had 103 discovery programs that are either completed, in progress, or under contract. It has a discovery partnership agreement with Eli Lilly and Company. AbCellera Biologics Inc. was founded in 2012 and is headquartered in Vancouver, Canada.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 8.797 - 8.881 8.881 - 8.933
Low: 7.929 - 8.034 8.034 - 8.098
Close: 8.247 - 8.422 8.422 - 8.528

Technical analysis

as of: 2022-01-25 4:21:52 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 14.79     One year: 18.57
Support: Support1: 7.42    Support2: 6.17
Resistance: Resistance1: 12.66    Resistance2: 15.90
Pivot: 10.65
Moving Average: MA(5): 8.82     MA(20): 11.50
MA(100): 15.33     MA(250): 22.42
MACD: MACD(12,26): -1.49     Signal(9): -1.18
Stochastic oscillator: %K(14,3): 10.49     %D(3): 5.85
RSI: RSI(14): 20.60
52-week: High: 54.26  Low: 7.42  Change(%): -84.2
Average Vol(K): 3-Month: 2065  10-Days: 2539

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
ABCL has closed above bottom band by 13.3%. Bollinger Bands are 48.6% wider than normal. The large width of the bands suggest high volatility as compared to Abcellera Biologics Inc's normal range. The bands have been in this wide range for 5 bars. This is a sign that the current trend might continue.

Headline News

Tue, 25 Jan 2022
Boasting A 22% Return On Equity, Is AbCellera Biologics Inc. (NASDAQ:ABCL) A Top Quality Stock? - Yahoo Finance

Sat, 22 Jan 2022
Validea Joel Greenblatt Strategy Daily Upgrade Report - 1/22/2022 - Nasdaq

Fri, 14 Jan 2022
U.S. pharmaceutical giants cozy up to B.C. biotechs - Business in Vancouver

Thu, 06 Jan 2022
AbCellera Biologics Inc (ABCL) has gained 1.06% Thursday In Premarket Trading - InvestorsObserver

Wed, 29 Dec 2021
Further weakness as AbCellera Biologics (NASDAQ:ABCL) drops 13% this week, taking one-year losses to 65% - Simply Wall St

Wed, 10 Nov 2021
AbCellera Biologics Inc. (ABCL) Q3 2021 Earnings Call Transcript - Motley Fool

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 282
Shares Float (M) 179
% Held by Insiders 30.25
% Held by Institutions 43.70
Shares Short (K) 10,570
Shares Short P. Month (K) 11,220

Stock Financials

EPS 0.640
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 3.390
Profit Margin 47.44
Operating Margin 64.34
Return on Assets (ttm) 27.1
Return on Equity (ttm) 40.4
Qtrly Rev. Growth -41.2
Gross Profit (p.s.) 0.627
Sales Per Share 1.576
EBITDA (p.s.) 1.060
Qtrly Earnings Growth
Operating Cash Flow (M) 263
Levered Free Cash Flow (M) 168

Stock Valuations

PE Ratio 13.08
PEG Ratio
Price to Book value 2.47
Price to Sales 5.31
Price to Cash Flow

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.